Introduction:Basic information about CAS 147816-24-8|Cefcapene pivoxil hydrochloride hydrate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Cefcapene pivoxil hydrochloride hydrate |
|---|
| CAS Number | 147816-24-8 | Molecular Weight | 622.111 |
|---|
| Density | 1.47 g/cm3 | Boiling Point | 888.4ºC at 760 mmHg |
|---|
| Molecular Formula | C23H32ClN5O9S2 | Melting Point | 158-164ºC |
|---|
| MSDS | / | Flash Point | 491.1ºC |
|---|
Names
| Name | Cefcapene Pivoxil Hydrochloride Monohydrate |
|---|
| Synonym | More Synonyms |
|---|
Cefcapene pivoxil hydrochloride hydrate BiologicalActivity
| Description | Cefcapene pivoxil hydrochloride hydrate is a prodrug and an orally active 3rd-generation cephalosporin with broad-spectrum of anti-bacterial activity[1]. Cefcapene pivoxil hydrochloride hydrate is used for the study of palmoplantar pustulosis (PPP) and other infectious diseases[2]. |
|---|
| Related Catalog | Research Areas >>InfectionSignaling Pathways >>Anti-infection >>Bacterial |
|---|
| Target | IC50: bacterial[1] |
|---|
| In Vivo | Cefcapene pivoxil hydrochloride hydrate (oral administration; 100mg/kg; 4 days) is effective against invasive BLNAR strains in mice lung, it stimates peak antibiotic concentrations of 1 to 2 μg/ml in the blood of mice from 30 to 120 min after intragastric administration[3]. Animal Model: Four-week-old female C57BL/6J mice with bacterial suspension in BSG (1×109 CFU)[3] Dosage: 100 mg/kg Administration: Oral administration; 100mg/kg; 4 days Result: Was against H. influenzae colonization in mouse lung. |
|---|
| References | [1]. Murakami M, et al. Cefcapene Pivoxil Hydrochloride Is a Potentially New Treatment for Palmoplantar Pustulosis with Pustulotic Arthro-Osteitis.Dermatology. 2015;231(4):304-11. [2]. Kawada A, et al. Drug eruption induced by cefcapene pivoxil hydrochloride.Contact Dermatitis. 2001 Mar;44(3):197. [3]. Sekiya Y, et al. Comparative efficacies of different antibiotic treatments to eradicate nontypeable Haemophilus influenzae infection.BMC Infect Dis. 2008 Feb 7;8:15. [4]. Sekiya Y, et al. Comparative efficacies of different antibiotic treatments to eradicate nontypeable Haemophilus influenzae infection.BMC Infect Dis. 2008 Feb 7;8:15. |
|---|
Chemical & Physical Properties
| Density | 1.47 g/cm3 |
|---|
| Boiling Point | 888.4ºC at 760 mmHg |
|---|
| Melting Point | 158-164ºC |
|---|
| Molecular Formula | C23H32ClN5O9S2 |
|---|
| Molecular Weight | 622.111 |
|---|
| Flash Point | 491.1ºC |
|---|
| Exact Mass | 621.132996 |
|---|
| PSA | 256.01000 |
|---|
| LogP | 3.70600 |
|---|
| Vapour Pressure | 3.51E-32mmHg at 25°C |
|---|
| InChIKey | LUXIJPQYUCFVAL-XRLCNELCSA-N |
|---|
| SMILES | CCC=C(C(=O)NC1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(COC(N)=O)CSC12)c1csc(N)n1.Cl.O |
|---|
| Storage condition | 0-10°C |
|---|
Safety Information
| RTECS | XI0325000 |
|---|
| HS Code | 2941905990 |
|---|
Customs
Synonyms
| CEFCAPENE PIVOXIL HYDROCHLORIDE HYDRATE |
| [(2,2-Dimethylpropanoyl)oxy]methyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-pentenoyl]amino}-3-[(carbamoyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride hydrate |
| Flomox |
| 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-1-oxo-2-penten-1-yl]amino]-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R,7R)-, hydrochloride, hydrate (1:1:1) |
| Cefcapene pivoxil hydrochloride |
| Cefcapene pivoxil hydrochloride monohydrate |